Welcome and Introduction to Our Patient: A Complex Case at a Young Age
Panel chair Philip Scheltens, MD, PhD, introduces the symposium’s topics, objectives, and expert panelists before briefly discussing the burden and current system constraints of the early diagnosis of Alzheimer’s disease. He then introduces a case study of a patient with the early stages of early-onset atypical Alzheimer’s disease, which will be followed throughout the symposia, from initial presentation to receiving a diagnosis.
Key Learning Objectives for Biogen’s AAT-AD/PD 2020 Symposium:
- Understand the importance of an early diagnosis of Alzheimer’s disease
- Assess the current healthcare system readiness for a paradigm shift to early diagnosis
- Gain insights on how cognitive assessment tools and imaging biomarkers can be used to distinguish between different subtypes of Alzheimer’s disease
- Increase understanding of the differences between the pathology of familial or sporadic early-onset and late-onset Alzheimer’s disease
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.